An international Delphi consensus statement on metabolic dysfunction-associated fatty liver disease and risk of chronic kidney disease
- Autores
- Sun, Dan Qin; Targher, Giovanni; Byrne, Christopher D.; Wheeler, David C.; Wong, Vincent Wai Sun; Fan, Jian Gao; Tilg, Herbert; Yuan, Wei Jie; Wanner, Christoph; Gao, Xin; Long, Michelle T.; Kanbay, Mehmet; Nguyen, Mindie H.; Navaneethan, Sankar D.; Yilmaz, Yusuf; Huang, Yuli; Gani, Rino A.; Marzuillo, Pierluigi; Boursier, Jérôme; Zhang, Huijie; Jung, Chan Young; Chai, Jin; Valenti, Luca; Papatheodoridis, George; Sookoian, Silvia Cristina; Chunsun, Dai; Eslam, Mohammed; Wei, Lai; George, Jacob; Zheng, Ming Hua
- Año de publicación
- 2023
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- Background: With the rising global prevalence of fatty liver disease related to metabolic dysfunction, the association of this common liver condition with chronic kidney disease (CKD) has become increasingly evident. In 2020, the more inclusive term metabolic dysfunction-associated fatty liver disease (MAFLD) was proposed to replace the term non-alcoholic fatty liver disease (NAFLD). The observed association between MAFLD and CKD and our understanding that CKD can be a consequence of underlying metabolic dysfunction support the notion that individuals with MAFLD are at higher risk of having and developing CKD compared with those without MAFLD. However, to date, there is no appropriate guidance on CKD in individuals with MAFLD. Furthermore, there has been little attention paid to the link between MAFLD and CKD in the Nephrology community. Methods and Results: Using a Delphi-based approach, a multidisciplinary panel of 50 international experts from 26 countries reached a consensus on some of the open research questions regarding the link between MAFLD and CKD. Conclusions: This Delphi-based consensus statement provided guidance on the epidemiology, mechanisms, management and treatment of MAFLD and CKD, as well as the relationship between the severity of MAFLD and risk of CKD, which establish a framework for the early prevention and management of these two common and interconnected diseases.
Fil: Sun, Dan Qin. Jiangnan University Medical Center; China. Nantong University; China
Fil: Targher, Giovanni. Azienda Ospedaliera Universitaria Integrata Verona; Italia
Fil: Byrne, Christopher D.. University of Southampton; Reino Unido
Fil: Wheeler, David C.. University College London; Estados Unidos
Fil: Wong, Vincent Wai Sun. Chinese University of Hong Kong; China
Fil: Fan, Jian Gao. Shanghai Jiao Tong University; China
Fil: Tilg, Herbert. Medical University Innsbruck; Austria
Fil: Yuan, Wei Jie. Shanghai Jiao Tong University; China
Fil: Wanner, Christoph. Würzburg University Clinic; Alemania
Fil: Gao, Xin. Fudan University; China
Fil: Long, Michelle T.. Boston University School of Medicine; Estados Unidos
Fil: Kanbay, Mehmet. Koc University School of Medicine; Turquía
Fil: Nguyen, Mindie H.. Stanford University Medical Center; Estados Unidos
Fil: Navaneethan, Sankar D.. Baylor College of Medicine; Estados Unidos
Fil: Yilmaz, Yusuf. Marmara University; Turquía. Recep Tayyip Erdoğan University; Turquía
Fil: Huang, Yuli. Southern Medical University; China
Fil: Gani, Rino A.. Universitas Indonesia; Indonesia
Fil: Marzuillo, Pierluigi. Università della Campania “Luigi Vanvitelli”; Italia
Fil: Boursier, Jérôme. Angers University; Francia
Fil: Zhang, Huijie. Southern Medical University; China
Fil: Jung, Chan Young. Yonsei University; Corea del Sur
Fil: Chai, Jin. Army Medical University; China
Fil: Valenti, Luca. Università degli Studi di Milano; Italia
Fil: Papatheodoridis, George. Kapodistrian University of Athens; Grecia
Fil: Sookoian, Silvia Cristina. Centro de Investigacion Traslacional En Salud (cenitres) ; Facultad de Cs. de la Salud ; Universidad Maimonides; . Universidad Abierta Interamericana; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina
Fil: Chunsun, Dai. Nanjing Medical University; China
Fil: Eslam, Mohammed. University of Sydney; Australia
Fil: Wei, Lai. Tsinghua University; China
Fil: George, Jacob. University of Sydney; Australia
Fil: Zheng, Ming Hua. Wenzhou Medical University; China - Materia
-
NAFLD
NASH
CKD
CONSENSUS - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- https://creativecommons.org/licenses/by-nc-nd/2.5/ar/
- Repositorio
.jpg)
- Institución
- Consejo Nacional de Investigaciones Científicas y Técnicas
- OAI Identificador
- oai:ri.conicet.gov.ar:11336/221030
Ver los metadatos del registro completo
| id |
CONICETDig_1530a85a88ced1ea35919e5561bc5ee9 |
|---|---|
| oai_identifier_str |
oai:ri.conicet.gov.ar:11336/221030 |
| network_acronym_str |
CONICETDig |
| repository_id_str |
3498 |
| network_name_str |
CONICET Digital (CONICET) |
| spelling |
An international Delphi consensus statement on metabolic dysfunction-associated fatty liver disease and risk of chronic kidney diseaseSun, Dan QinTargher, GiovanniByrne, Christopher D.Wheeler, David C.Wong, Vincent Wai SunFan, Jian GaoTilg, HerbertYuan, Wei JieWanner, ChristophGao, XinLong, Michelle T.Kanbay, MehmetNguyen, Mindie H.Navaneethan, Sankar D.Yilmaz, YusufHuang, YuliGani, Rino A.Marzuillo, PierluigiBoursier, JérômeZhang, HuijieJung, Chan YoungChai, JinValenti, LucaPapatheodoridis, GeorgeSookoian, Silvia CristinaChunsun, DaiEslam, MohammedWei, LaiGeorge, JacobZheng, Ming HuaNAFLDNASHCKDCONSENSUShttps://purl.org/becyt/ford/3.2https://purl.org/becyt/ford/3Background: With the rising global prevalence of fatty liver disease related to metabolic dysfunction, the association of this common liver condition with chronic kidney disease (CKD) has become increasingly evident. In 2020, the more inclusive term metabolic dysfunction-associated fatty liver disease (MAFLD) was proposed to replace the term non-alcoholic fatty liver disease (NAFLD). The observed association between MAFLD and CKD and our understanding that CKD can be a consequence of underlying metabolic dysfunction support the notion that individuals with MAFLD are at higher risk of having and developing CKD compared with those without MAFLD. However, to date, there is no appropriate guidance on CKD in individuals with MAFLD. Furthermore, there has been little attention paid to the link between MAFLD and CKD in the Nephrology community. Methods and Results: Using a Delphi-based approach, a multidisciplinary panel of 50 international experts from 26 countries reached a consensus on some of the open research questions regarding the link between MAFLD and CKD. Conclusions: This Delphi-based consensus statement provided guidance on the epidemiology, mechanisms, management and treatment of MAFLD and CKD, as well as the relationship between the severity of MAFLD and risk of CKD, which establish a framework for the early prevention and management of these two common and interconnected diseases.Fil: Sun, Dan Qin. Jiangnan University Medical Center; China. Nantong University; ChinaFil: Targher, Giovanni. Azienda Ospedaliera Universitaria Integrata Verona; ItaliaFil: Byrne, Christopher D.. University of Southampton; Reino UnidoFil: Wheeler, David C.. University College London; Estados UnidosFil: Wong, Vincent Wai Sun. Chinese University of Hong Kong; ChinaFil: Fan, Jian Gao. Shanghai Jiao Tong University; ChinaFil: Tilg, Herbert. Medical University Innsbruck; AustriaFil: Yuan, Wei Jie. Shanghai Jiao Tong University; ChinaFil: Wanner, Christoph. Würzburg University Clinic; AlemaniaFil: Gao, Xin. Fudan University; ChinaFil: Long, Michelle T.. Boston University School of Medicine; Estados UnidosFil: Kanbay, Mehmet. Koc University School of Medicine; TurquíaFil: Nguyen, Mindie H.. Stanford University Medical Center; Estados UnidosFil: Navaneethan, Sankar D.. Baylor College of Medicine; Estados UnidosFil: Yilmaz, Yusuf. Marmara University; Turquía. Recep Tayyip Erdoğan University; TurquíaFil: Huang, Yuli. Southern Medical University; ChinaFil: Gani, Rino A.. Universitas Indonesia; IndonesiaFil: Marzuillo, Pierluigi. Università della Campania “Luigi Vanvitelli”; ItaliaFil: Boursier, Jérôme. Angers University; FranciaFil: Zhang, Huijie. Southern Medical University; ChinaFil: Jung, Chan Young. Yonsei University; Corea del SurFil: Chai, Jin. Army Medical University; ChinaFil: Valenti, Luca. Università degli Studi di Milano; ItaliaFil: Papatheodoridis, George. Kapodistrian University of Athens; GreciaFil: Sookoian, Silvia Cristina. Centro de Investigacion Traslacional En Salud (cenitres) ; Facultad de Cs. de la Salud ; Universidad Maimonides; . Universidad Abierta Interamericana; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; ArgentinaFil: Chunsun, Dai. Nanjing Medical University; ChinaFil: Eslam, Mohammed. University of Sydney; AustraliaFil: Wei, Lai. Tsinghua University; ChinaFil: George, Jacob. University of Sydney; AustraliaFil: Zheng, Ming Hua. Wenzhou Medical University; ChinaAME Publishing Company2023-06info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/221030Sun, Dan Qin; Targher, Giovanni; Byrne, Christopher D.; Wheeler, David C.; Wong, Vincent Wai Sun; et al.; An international Delphi consensus statement on metabolic dysfunction-associated fatty liver disease and risk of chronic kidney disease; AME Publishing Company; Hepatobiliary Surgery and Nutrition; 12; 3; 6-2023; 386-4032304-38812304-389XCONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/url/https://hbsn.amegroups.com/article/view/110403/htmlinfo:eu-repo/semantics/altIdentifier/doi/10.21037/hbsn-22-421info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-nd/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-29T09:40:57Zoai:ri.conicet.gov.ar:11336/221030instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-29 09:40:58.156CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse |
| dc.title.none.fl_str_mv |
An international Delphi consensus statement on metabolic dysfunction-associated fatty liver disease and risk of chronic kidney disease |
| title |
An international Delphi consensus statement on metabolic dysfunction-associated fatty liver disease and risk of chronic kidney disease |
| spellingShingle |
An international Delphi consensus statement on metabolic dysfunction-associated fatty liver disease and risk of chronic kidney disease Sun, Dan Qin NAFLD NASH CKD CONSENSUS |
| title_short |
An international Delphi consensus statement on metabolic dysfunction-associated fatty liver disease and risk of chronic kidney disease |
| title_full |
An international Delphi consensus statement on metabolic dysfunction-associated fatty liver disease and risk of chronic kidney disease |
| title_fullStr |
An international Delphi consensus statement on metabolic dysfunction-associated fatty liver disease and risk of chronic kidney disease |
| title_full_unstemmed |
An international Delphi consensus statement on metabolic dysfunction-associated fatty liver disease and risk of chronic kidney disease |
| title_sort |
An international Delphi consensus statement on metabolic dysfunction-associated fatty liver disease and risk of chronic kidney disease |
| dc.creator.none.fl_str_mv |
Sun, Dan Qin Targher, Giovanni Byrne, Christopher D. Wheeler, David C. Wong, Vincent Wai Sun Fan, Jian Gao Tilg, Herbert Yuan, Wei Jie Wanner, Christoph Gao, Xin Long, Michelle T. Kanbay, Mehmet Nguyen, Mindie H. Navaneethan, Sankar D. Yilmaz, Yusuf Huang, Yuli Gani, Rino A. Marzuillo, Pierluigi Boursier, Jérôme Zhang, Huijie Jung, Chan Young Chai, Jin Valenti, Luca Papatheodoridis, George Sookoian, Silvia Cristina Chunsun, Dai Eslam, Mohammed Wei, Lai George, Jacob Zheng, Ming Hua |
| author |
Sun, Dan Qin |
| author_facet |
Sun, Dan Qin Targher, Giovanni Byrne, Christopher D. Wheeler, David C. Wong, Vincent Wai Sun Fan, Jian Gao Tilg, Herbert Yuan, Wei Jie Wanner, Christoph Gao, Xin Long, Michelle T. Kanbay, Mehmet Nguyen, Mindie H. Navaneethan, Sankar D. Yilmaz, Yusuf Huang, Yuli Gani, Rino A. Marzuillo, Pierluigi Boursier, Jérôme Zhang, Huijie Jung, Chan Young Chai, Jin Valenti, Luca Papatheodoridis, George Sookoian, Silvia Cristina Chunsun, Dai Eslam, Mohammed Wei, Lai George, Jacob Zheng, Ming Hua |
| author_role |
author |
| author2 |
Targher, Giovanni Byrne, Christopher D. Wheeler, David C. Wong, Vincent Wai Sun Fan, Jian Gao Tilg, Herbert Yuan, Wei Jie Wanner, Christoph Gao, Xin Long, Michelle T. Kanbay, Mehmet Nguyen, Mindie H. Navaneethan, Sankar D. Yilmaz, Yusuf Huang, Yuli Gani, Rino A. Marzuillo, Pierluigi Boursier, Jérôme Zhang, Huijie Jung, Chan Young Chai, Jin Valenti, Luca Papatheodoridis, George Sookoian, Silvia Cristina Chunsun, Dai Eslam, Mohammed Wei, Lai George, Jacob Zheng, Ming Hua |
| author2_role |
author author author author author author author author author author author author author author author author author author author author author author author author author author author author author |
| dc.subject.none.fl_str_mv |
NAFLD NASH CKD CONSENSUS |
| topic |
NAFLD NASH CKD CONSENSUS |
| purl_subject.fl_str_mv |
https://purl.org/becyt/ford/3.2 https://purl.org/becyt/ford/3 |
| dc.description.none.fl_txt_mv |
Background: With the rising global prevalence of fatty liver disease related to metabolic dysfunction, the association of this common liver condition with chronic kidney disease (CKD) has become increasingly evident. In 2020, the more inclusive term metabolic dysfunction-associated fatty liver disease (MAFLD) was proposed to replace the term non-alcoholic fatty liver disease (NAFLD). The observed association between MAFLD and CKD and our understanding that CKD can be a consequence of underlying metabolic dysfunction support the notion that individuals with MAFLD are at higher risk of having and developing CKD compared with those without MAFLD. However, to date, there is no appropriate guidance on CKD in individuals with MAFLD. Furthermore, there has been little attention paid to the link between MAFLD and CKD in the Nephrology community. Methods and Results: Using a Delphi-based approach, a multidisciplinary panel of 50 international experts from 26 countries reached a consensus on some of the open research questions regarding the link between MAFLD and CKD. Conclusions: This Delphi-based consensus statement provided guidance on the epidemiology, mechanisms, management and treatment of MAFLD and CKD, as well as the relationship between the severity of MAFLD and risk of CKD, which establish a framework for the early prevention and management of these two common and interconnected diseases. Fil: Sun, Dan Qin. Jiangnan University Medical Center; China. Nantong University; China Fil: Targher, Giovanni. Azienda Ospedaliera Universitaria Integrata Verona; Italia Fil: Byrne, Christopher D.. University of Southampton; Reino Unido Fil: Wheeler, David C.. University College London; Estados Unidos Fil: Wong, Vincent Wai Sun. Chinese University of Hong Kong; China Fil: Fan, Jian Gao. Shanghai Jiao Tong University; China Fil: Tilg, Herbert. Medical University Innsbruck; Austria Fil: Yuan, Wei Jie. Shanghai Jiao Tong University; China Fil: Wanner, Christoph. Würzburg University Clinic; Alemania Fil: Gao, Xin. Fudan University; China Fil: Long, Michelle T.. Boston University School of Medicine; Estados Unidos Fil: Kanbay, Mehmet. Koc University School of Medicine; Turquía Fil: Nguyen, Mindie H.. Stanford University Medical Center; Estados Unidos Fil: Navaneethan, Sankar D.. Baylor College of Medicine; Estados Unidos Fil: Yilmaz, Yusuf. Marmara University; Turquía. Recep Tayyip Erdoğan University; Turquía Fil: Huang, Yuli. Southern Medical University; China Fil: Gani, Rino A.. Universitas Indonesia; Indonesia Fil: Marzuillo, Pierluigi. Università della Campania “Luigi Vanvitelli”; Italia Fil: Boursier, Jérôme. Angers University; Francia Fil: Zhang, Huijie. Southern Medical University; China Fil: Jung, Chan Young. Yonsei University; Corea del Sur Fil: Chai, Jin. Army Medical University; China Fil: Valenti, Luca. Università degli Studi di Milano; Italia Fil: Papatheodoridis, George. Kapodistrian University of Athens; Grecia Fil: Sookoian, Silvia Cristina. Centro de Investigacion Traslacional En Salud (cenitres) ; Facultad de Cs. de la Salud ; Universidad Maimonides; . Universidad Abierta Interamericana; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina Fil: Chunsun, Dai. Nanjing Medical University; China Fil: Eslam, Mohammed. University of Sydney; Australia Fil: Wei, Lai. Tsinghua University; China Fil: George, Jacob. University of Sydney; Australia Fil: Zheng, Ming Hua. Wenzhou Medical University; China |
| description |
Background: With the rising global prevalence of fatty liver disease related to metabolic dysfunction, the association of this common liver condition with chronic kidney disease (CKD) has become increasingly evident. In 2020, the more inclusive term metabolic dysfunction-associated fatty liver disease (MAFLD) was proposed to replace the term non-alcoholic fatty liver disease (NAFLD). The observed association between MAFLD and CKD and our understanding that CKD can be a consequence of underlying metabolic dysfunction support the notion that individuals with MAFLD are at higher risk of having and developing CKD compared with those without MAFLD. However, to date, there is no appropriate guidance on CKD in individuals with MAFLD. Furthermore, there has been little attention paid to the link between MAFLD and CKD in the Nephrology community. Methods and Results: Using a Delphi-based approach, a multidisciplinary panel of 50 international experts from 26 countries reached a consensus on some of the open research questions regarding the link between MAFLD and CKD. Conclusions: This Delphi-based consensus statement provided guidance on the epidemiology, mechanisms, management and treatment of MAFLD and CKD, as well as the relationship between the severity of MAFLD and risk of CKD, which establish a framework for the early prevention and management of these two common and interconnected diseases. |
| publishDate |
2023 |
| dc.date.none.fl_str_mv |
2023-06 |
| dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
| format |
article |
| status_str |
publishedVersion |
| dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11336/221030 Sun, Dan Qin; Targher, Giovanni; Byrne, Christopher D.; Wheeler, David C.; Wong, Vincent Wai Sun; et al.; An international Delphi consensus statement on metabolic dysfunction-associated fatty liver disease and risk of chronic kidney disease; AME Publishing Company; Hepatobiliary Surgery and Nutrition; 12; 3; 6-2023; 386-403 2304-3881 2304-389X CONICET Digital CONICET |
| url |
http://hdl.handle.net/11336/221030 |
| identifier_str_mv |
Sun, Dan Qin; Targher, Giovanni; Byrne, Christopher D.; Wheeler, David C.; Wong, Vincent Wai Sun; et al.; An international Delphi consensus statement on metabolic dysfunction-associated fatty liver disease and risk of chronic kidney disease; AME Publishing Company; Hepatobiliary Surgery and Nutrition; 12; 3; 6-2023; 386-403 2304-3881 2304-389X CONICET Digital CONICET |
| dc.language.none.fl_str_mv |
eng |
| language |
eng |
| dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/url/https://hbsn.amegroups.com/article/view/110403/html info:eu-repo/semantics/altIdentifier/doi/10.21037/hbsn-22-421 |
| dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by-nc-nd/2.5/ar/ |
| eu_rights_str_mv |
openAccess |
| rights_invalid_str_mv |
https://creativecommons.org/licenses/by-nc-nd/2.5/ar/ |
| dc.format.none.fl_str_mv |
application/pdf application/pdf |
| dc.publisher.none.fl_str_mv |
AME Publishing Company |
| publisher.none.fl_str_mv |
AME Publishing Company |
| dc.source.none.fl_str_mv |
reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas |
| reponame_str |
CONICET Digital (CONICET) |
| collection |
CONICET Digital (CONICET) |
| instname_str |
Consejo Nacional de Investigaciones Científicas y Técnicas |
| repository.name.fl_str_mv |
CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas |
| repository.mail.fl_str_mv |
dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar |
| _version_ |
1844613295888138240 |
| score |
13.069144 |